Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | RA |
allergic to pistachios; I have recently developed multiple hypersensitivity reactions; Cat allergy; This is a spontaneous report received from a Consumer or other non HCP. A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Jan2021 as dose 2, single (Batch/Lot number: unknown) at the age of 28 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE1, SINGLE), for covid-19 immunisation. The following information was reported: ALLERGY TO ANIMAL (non-serious) with onset 2021, outcome "recovered with sequelae", described as "Cat allergy"; HYPERSENSITIVITY (non-serious) with onset 01Nov2021, outcome "recovered with sequelae", described as "I have recently developed multiple hypersensitivity reactions"; FOOD ALLERGY (non-serious) with onset 2024, outcome "recovered with sequelae", described as "allergic to pistachios". Therapeutic measures were taken as a result of hypersensitivity, allergy to animal, food allergy. Clinical course: Patient did not received any other vaccines within 4 weeks PRIOR to the vaccine for which you are reporting. Patient was not taking any other medications within 2 weeks of the event starting. Patient had recently developed multiple hypersensitivity reactions. Recently allergic to pistachios, and recent allergy symptoms to cats. Cat allergy started in 2021 and pistachio allergy developed in 2024. Treatment received for the adverse event Cetirizine . No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.